{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:15:26Z","timestamp":1792444526664,"version":"4.5.0"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003472","name":"Harbin Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003472","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.yexmp.2026.105033","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T21:03:45Z","timestamp":1772485425000},"page":"105033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Regulatory role of protein tyrosine phosphatases in hematopoiesis and leukemogenesis"],"prefix":"10.1016","volume":"145","author":[{"given":"Xiaoting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhuo","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"guangsen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2026.105033_bb0005","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jclinpath-2020-206927","article-title":"Protein tyrosine phosphatase receptor type C (PTPRC or CD45)","volume":"74","author":"Al Barashdi","year":"2021","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00277-023-05520-y","article-title":"CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy","volume":"103","author":"Al Barashdi","year":"2024","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0015","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/bloodadvances.2018028993","article-title":"Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia","volume":"3","author":"Alcantara","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.yexmp.2026.105033_bb0020","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049715","article-title":"Loss of Shp1 impairs myeloid cell function and causes lethal inflammation in zebrafish larvae","volume":"16","author":"Allers","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.yexmp.2026.105033_bb0025","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","article-title":"Protein tyrosine phosphatases in the human genome","volume":"117","author":"Alonso","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.yexmp.2026.105033_bb0030","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.31557\/APJCP.2021.22.12.3959","article-title":"Thymoquinone induces downregulation of BCR-ABL\/JAK\/STAT pathway and apoptosis in K562 Leukemia cells","volume":"22","author":"Al-Rawashde","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.yexmp.2026.105033_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ph15091123","article-title":"Thymoquinone inhibits JAK\/STAT and PI3K\/Akt\/mTOR signaling pathways in MV4-11 and K562 myeloid leukemia cells","volume":"15","author":"Al-Rawashde","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.yexmp.2026.105033_bb0040","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/path.2178","article-title":"Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia","volume":"212","author":"Amin","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26199700","article-title":"Curcumin and acute myeloid Leukemia: synergistic effects with targeted therapy","volume":"26","author":"Badagliacca","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2026.105033_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-025-00717-5","article-title":"Inhibition of EYA family tyrosine phosphatase activity reveals a therapeutic vulnerability and enhances Menin and DOT1L inhibitor efficacy in KMT2A-rearranged leukemia","volume":"14","author":"Badmus","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1053856","article-title":"Multi-omics analyses of tumor-associated immune-infiltrating cells with the novel immune checkpoint protein tyrosine phosphatase 1B (PTP1B) in extracellular matrix of brain-lower-grade-glioma (LGG) and uveal-melanoma (UVM)","volume":"13","author":"Bai","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0060","doi-asserted-by":"crossref","first-page":"38061","DOI":"10.18632\/oncotarget.5706","article-title":"CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia","volume":"6","author":"Bertoli","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexmp.2026.105033_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.835290","article-title":"Glycerophosphoinositol promotes apoptosis of chronic lymphocytic Leukemia cells by enhancing Bax expression and activation","volume":"12","author":"Boncompagni","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0070","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1126\/science.adh7950","article-title":"DNA damage induces p53-independent apoptosis through ribosome stalling","volume":"384","author":"Boon","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.yexmp.2026.105033_bb0075","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1182\/blood-2006-08-044370","article-title":"TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-{gamma}","volume":"109","author":"Bourdeau","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2026.105033_bb0080","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41375-019-0512-y","article-title":"Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia","volume":"33","author":"Branford","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2026.105033_bb0085","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2539::AID-IMMU2539>3.0.CO;2-M","article-title":"Dephosphorylation of ZAP-70 and inhibition of T cell activation by activated SHP1","volume":"29","author":"Brockdorff","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9859","article-title":"Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis","volume":"6","author":"Bunda","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexmp.2026.105033_bb0095","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201541","article-title":"Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection","volume":"218","author":"Caiado","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexmp.2026.105033_bb0100","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170065","article-title":"PRL2 inhibition elevates PTEN protein and ameliorates progression of acute myeloid leukemia","volume":"8","author":"Carlock","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.yexmp.2026.105033_bb0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156800908784293659","article-title":"The PTEN\/PI3K\/AKT signalling pathway in cancer, therapeutic implications","volume":"8","author":"Carnero","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.yexmp.2026.105033_bb0110","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1182\/blood-2010-11-319517","article-title":"Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells","volume":"117","author":"Chan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2026.105033_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/pro.70016","article-title":"Allosteric regulation of the tyrosine phosphatase PTP1B by a protein-protein interaction","volume":"34","author":"Chartier","year":"2025","journal-title":"Protein Sci."},{"key":"10.1016\/j.yexmp.2026.105033_bb0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nature18621","article-title":"Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases","volume":"535","author":"Chen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2026.105033_bb0125","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4149\/neo_2021_210301N265","article-title":"The combination of PRL-3 inhibitor with sorafenib synergistically promotes AML apoptosis","volume":"68","author":"Chen","year":"2021","journal-title":"Neoplasma"},{"key":"10.1016\/j.yexmp.2026.105033_bb0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.2022016580","article-title":"PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371","volume":"141","author":"Chen","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2026.105033_bb0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/1541-7786.MCR-23-0115","article-title":"PRL2 phosphatase promotes oncogenic KIT Signaling in Leukemia cells through modulating CBL phosphorylation","volume":"22","author":"Chen","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.yexmp.2026.105033_bb0140","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41388-018-0526-3","article-title":"Non-canonical activation of \u03b2-catenin by PRL-3 phosphatase in acute myeloid leukemia","volume":"38","author":"Chong","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.yexmp.2026.105033_bb0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tibs.2017.11.008","article-title":"TCR Signaling: mechanisms of initiation and propagation","volume":"43","author":"Courtney","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.yexmp.2026.105033_bb0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.1994.tb04972.x","article-title":"CD45 isoform expression on human haemopoietic cells at different stages of development","volume":"88","author":"Craig","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0155","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1074\/jbc.M113.512079","article-title":"Phosphatase of regenerating liver 2 (PRL2) deficiency impairs kit signaling and spermatogenesis","volume":"289","author":"Dong","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexmp.2026.105033_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202303818","article-title":"Small molecule degraders of protein tyrosine phosphatase 1B and T-cell protein tyrosine phosphatase for cancer immunotherapy","volume":"62","author":"Dong","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.yexmp.2026.105033_bb0165","doi-asserted-by":"crossref","first-page":"9442","DOI":"10.18632\/oncotarget.24253","article-title":"PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells","volume":"9","author":"Drube","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexmp.2026.105033_bb0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/cas.15580","article-title":"Targeting the PTP1B-Bcr-Abl1 interaction for the degradation of T315I mutant Bcr-Abl1 in chronic myeloid leukemia","volume":"114","author":"Elgehama","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.yexmp.2026.105033_bb0175","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1074\/jbc.M309537200","article-title":"Subdomain X of the kinase domain of Lck binds CD45 and facilitates dephosphorylation","volume":"279","author":"Felberg","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexmp.2026.105033_bb0180","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jcb.22695","article-title":"Gab1 mediates hepatocyte growth factor-stimulated mitogenicity and morphogenesis in multipotent myeloid cells","volume":"111","author":"Felici","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.yexmp.2026.105033_bb0185","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1074\/jbc.M110.157420","article-title":"Identification of new substrates of the protein-tyrosine phosphatase PTP1B by Bayesian integration of proteome evidence","volume":"286","author":"Ferrari","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexmp.2026.105033_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107957","article-title":"PTPN2 deficiency enhances programmed T cell expansion and survival capacity of activated T cells","volume":"32","author":"Flosbach","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.yexmp.2026.105033_bb0195","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/JLB.2A0421-221R","article-title":"Gab2 promotes acute myeloid leukemia growth and migration through the SHP2-Erk-CREB signaling pathway","volume":"112","author":"Gong","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0200","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3324\/haematol.2011.046896","article-title":"Genetic disruption of the PI3K regulatory subunits, p85\u03b1, p55\u03b1, and p50\u03b1, normalizes mutant PTPN11-induced hypersensitivity to GM-CSF","volume":"97","author":"Goodwin","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.yexmp.2026.105033_bb0205","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1182\/blood-2015-06-653006","article-title":"Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1","volume":"127","author":"Gu","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2026.105033_bb0210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/leu.2017.250","article-title":"SHP2 is required for BCR-ABL1-induced hematologic neoplasia","volume":"32","author":"Gu","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2026.105033_bb0215","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature06933","article-title":"Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation","volume":"453","author":"Guo","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2026.105033_bb0220","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1073\/pnas.1006937108","article-title":"Suppression of leukemia development caused by PTEN loss","volume":"108","author":"Guo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexmp.2026.105033_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100923","article-title":"Immunometabolic control of hematopoiesis","volume":"77","author":"Hajishengallis","year":"2021","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.yexmp.2026.105033_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020334","article-title":"CD45-directed CAR-T cells with CD45 knockout efficiently kill myeloid Leukemia and lymphoma cells in vitro even after extended culture","volume":"16","author":"Harfmann","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.yexmp.2026.105033_bb0235","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nm.2119","article-title":"Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells","volume":"16","author":"Himburg","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexmp.2026.105033_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2018.07.003","article-title":"Distinct bone marrow sources of pleiotrophin control hematopoietic stem cell maintenance and regeneration","volume":"23","author":"Himburg","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yexmp.2026.105033_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-08049-8","article-title":"PTEN\/PI3K\/Akt pathway alters sensitivity of T-cell acute lymphoblastic leukemia to L-asparaginase","volume":"12","author":"Hlozkova","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2026.105033_bb0250","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2014.08.060","article-title":"Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver","volume":"88","author":"Hoeger","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.yexmp.2026.105033_bb0255","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrc3037","article-title":"PTEN loss in the continuum of common cancers, rare syndromes and mouse models","volume":"11","author":"Hollander","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexmp.2026.105033_bb0260","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbrc.2016.07.048","article-title":"Lack of SIRP\u03b1 phosphorylation and concomitantly reduced SHP-2-PI3K-Akt2 signaling decrease osteoblast differentiation","volume":"478","author":"Holm","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexmp.2026.105033_bb0265","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/2326-6066.CIR-19-0008","article-title":"TAM family receptor kinase inhibition reverses MDSC-mediated suppression and augments anti-PD-1 therapy in melanoma","volume":"7","author":"Holtzhausen","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.yexmp.2026.105033_bb0270","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jhep.2013.09.028","article-title":"PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-\u03baB","volume":"60","author":"Hou","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0275","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1101\/gad.192054.112","article-title":"A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation","volume":"26","author":"Huang","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexmp.2026.105033_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189098","article-title":"All eyes on Eya: a unique transcriptional co-activator and phosphatase in cancer","volume":"1879","author":"Hughes","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.yexmp.2026.105033_bb0285","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.imlet.2004.05.011","article-title":"CD45: direct and indirect government of immune regulation","volume":"94","author":"Huntington","year":"2004","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.yexmp.2026.105033_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-86875-y","article-title":"Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients","volume":"11","author":"Ismail","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2026.105033_bb0295","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/ajh.27443","article-title":"Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring","volume":"99","author":"Jabbour","year":"2024","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0300","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01027-21","article-title":"Suppression of JAK-STAT signaling by Epstein-Barr virus tegument protein BGLF2 through recruitment of SHP1 phosphatase and promotion of STAT2 degradation","volume":"95","author":"Jangra","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0305","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc2980","article-title":"Inside the human cancer tyrosine phosphatome","volume":"11","author":"Julien","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexmp.2026.105033_bb0310","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12032-013-0517-8","article-title":"Deregulation of protein phosphatase expression in acute myeloid leukemia","volume":"30","author":"Kabir","year":"2013","journal-title":"Med. Oncol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0315","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/14728222.2022.2066518","article-title":"Targeting SHP2 phosphatase in hematological malignancies","volume":"26","author":"Kanumuri","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.yexmp.2026.105033_bb0320","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00633","article-title":"Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation","volume":"2","author":"Kerenyi","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.yexmp.2026.105033_bb0325","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nm.4310","article-title":"Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia","volume":"23","author":"Kesarwani","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexmp.2026.105033_bb0330","doi-asserted-by":"crossref","DOI":"10.3791\/58194-v","article-title":"Methods for evaluating the role of c-Fos and Dusp1 in oncogene dependence","author":"Kesarwani","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.yexmp.2026.105033_bb0335","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2026.105033_bb0340","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1182\/blood-2010-10-314286","article-title":"PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia","volume":"117","author":"Kleppe","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2026.105033_bb0345","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/stem.1672","article-title":"PRL2\/PTP4A2 phosphatase is important for hematopoietic stem cell self-renewal","volume":"32","author":"Kobayashi","year":"2014","journal-title":"Stem Cells."},{"key":"10.1016\/j.yexmp.2026.105033_bb0350","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/leu.2016.340","article-title":"Phosphatase PRL2 promotes oncogenic NOTCH1-induced T-cell leukemia","volume":"31","author":"Kobayashi","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2026.105033_bb0355","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/leu.2017.67","article-title":"Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia","volume":"31","author":"Kobayashi","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2026.105033_bb0360","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/stem.2559","article-title":"Protein tyrosine phosphatase PRL2 mediates notch and kit signals in early T cell progenitors","volume":"35","author":"Kobayashi","year":"2017","journal-title":"Stem Cells."},{"key":"10.1016\/j.yexmp.2026.105033_bb0365","first-page":"108","article-title":"DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression","volume":"4","author":"Kong","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.yexmp.2026.105033_bb0370","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1128\/MCB.22.11.3875-3891.2002","article-title":"Role of SHP-2 in fibroblast growth factor receptor-mediated suppression of myogenesis in C2C12 myoblasts","volume":"22","author":"Kontaridis","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0375","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1074\/mcp.RA117.000538","article-title":"Protein tyrosine phosphatase receptor type G (PTPRG) controls fibroblast growth factor receptor (FGFR) 1 activity and influences sensitivity to FGFR kinase inhibitors","volume":"17","author":"Kostas","year":"2018","journal-title":"Mol. Cell. Proteomics."},{"key":"10.1016\/j.yexmp.2026.105033_bb0380","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nchembio.1528","article-title":"Targeting the disordered C terminus of PTP1B with an allosteric inhibitor","volume":"10","author":"Krishnan","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0385","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.immuni.2016.01.014","article-title":"CD45 phosphatase inhibits STAT3 transcription factor activity in myeloid cells and promotes tumor-associated macrophage differentiation","volume":"44","author":"Kumar","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.yexmp.2026.105033_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26040848","article-title":"Polyphyllin D shows anticancer effect through a selective inhibition of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP2)","volume":"26","author":"Kwon","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.yexmp.2026.105033_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.897791","article-title":"Honokiol induces ferroptosis by upregulating HMOX1 in acute myeloid Leukemia cells","volume":"13","author":"Lai","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0400","doi-asserted-by":"crossref","first-page":"14094","DOI":"10.1073\/pnas.95.24.14094","article-title":"Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells","volume":"95","author":"LaMontagne","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexmp.2026.105033_bb0405","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1158\/0008-5472.CAN-17-0946","article-title":"Deficiency in protein tyrosine phosphatase PTP1B shortens lifespan and leads to development of acute Leukemia","volume":"78","author":"Le Sommer","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexmp.2026.105033_bb0410","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.phrs.2019.04.011","article-title":"Important roles of protein tyrosine phosphatase PTPN12 in tumor progression","volume":"144","author":"Lee","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.yexmp.2026.105033_bb0415","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.3892\/or.2014.3098","article-title":"Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia","volume":"31","author":"Li","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexmp.2026.105033_bb0420","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/leu.2016.326","article-title":"Inhibition of the Gab2\/PI3K\/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations","volume":"31","author":"Liu","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2026.105033_bb0425","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cam4.1435","article-title":"Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy","volume":"7","author":"Lori","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.yexmp.2026.105033_bb0430","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/mc.22962","article-title":"Morin-dependent inhibition of low molecular weight protein tyrosine phosphatase (LMW-PTP) restores sensitivity to apoptosis during colon carcinogenesis: studies in vitro and in vivo, in an Apc-driven model of colon cancer","volume":"58","author":"Lori","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.yexmp.2026.105033_bb0435","first-page":"981","article-title":"Eya2 is critical for the E2A-HLF-mediated immortalization of mouse hematopoietic stem\/progenitor cells","volume":"54","author":"Maharjan","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0440","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.yexmp.2026.105033_bb0445","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1016\/j.bmcl.2013.04.092","article-title":"Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells","volume":"23","author":"Min","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.yexmp.2026.105033_bb0450","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.1401841","article-title":"Protein tyrosine phosphatase receptor type \u03b3 is a JAK phosphatase and negatively regulates leukocyte integrin activation","volume":"194","author":"Mirenda","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0455","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/mc.23078","article-title":"The role of T-cell protein tyrosine phosphatase in epithelial carcinogenesis","volume":"58","author":"Morales","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.yexmp.2026.105033_bb0460","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/leu.2014.341","article-title":"PTPROt-mediated regulation of p53\/Foxm1 suppresses leukemic phenotype in a CLL mouse model","volume":"29","author":"Motiwala","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2026.105033_bb0465","article-title":"Advances in acute myeloid leukemia","volume":"375","author":"Newell","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.yexmp.2026.105033_bb0470","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood.V93.6.1809.406k35_1809_1816","article-title":"Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors","volume":"93","author":"Nishida","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2026.105033_bb0475","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00585-16","article-title":"Eya2, a target activated by Plzf, is critical for PLZF-RARA-induced leukemogenesis","volume":"37","author":"Ono","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114442","article-title":"The progress of small-molecules and degraders against BCR-ABL for the treatment of CML","volume":"238","author":"Pan","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.yexmp.2026.105033_bb0485","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/emmm.201202183","article-title":"Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia","volume":"5","author":"Park","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.yexmp.2026.105033_bb0490","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13673-w","article-title":"TC-PTP regulates the IL-7 transcriptional response during murine early T cell development","volume":"7","author":"Pike","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2026.105033_bb0495","article-title":"Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML","volume":"4","author":"Popescu","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.yexmp.2026.105033_bb0500","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2217\/ijh-2017-0011","article-title":"Targeting sphingosine kinase 1 in acute myeloid leukemia: translation to clinic","volume":"6","author":"Powell","year":"2017","journal-title":"Int. J. Hematol. Oncol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0505","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/cncr.28668","article-title":"Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD-negative acute myeloid leukemia","volume":"120","author":"Qu","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.yexmp.2026.105033_bb0510","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1172\/JCI77866","article-title":"Protein tyrosine phosphatase-\u03c3 regulates hematopoietic stem cell-repopulating capacity","volume":"125","author":"Quarmyne","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexmp.2026.105033_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101477","article-title":"Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells","volume":"298","author":"Raveendra-Panickar","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexmp.2026.105033_bb0520","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/s41375-019-0676-5","article-title":"SHP1 regulates a STAT6-ITGB3 axis in FLT3ITD-positive AML cells","volume":"34","author":"Reich","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2026.105033_bb0525","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1039\/C6OB00946H","article-title":"Photooxygenation of an amino-thienopyridone yields a more potent PTP4A3 inhibitor","volume":"14","author":"Salamoun","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.yexmp.2026.105033_bb0530","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/prot.25236","article-title":"Insights into the interaction of high potency inhibitor IRC-083864 with phosphatase CDC25","volume":"85","author":"Sarkis","year":"2017","journal-title":"Proteins"},{"key":"10.1016\/j.yexmp.2026.105033_bb0535","doi-asserted-by":"crossref","first-page":"7048","DOI":"10.1158\/0008-5472.CAN-14-1470","article-title":"Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia","volume":"74","author":"Schubbert","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexmp.2026.105033_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121939","article-title":"In chronic lymphocytic Leukemia the JAK2\/STAT3 pathway is constitutively activated and its inhibition leads to CLL cell death unaffected by the protective bone marrow microenvironment","volume":"11","author":"Severin","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.yexmp.2026.105033_bb0545","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1002\/anie.200454237","article-title":"23-oxa-analogues of OSW-1: efficient synthesis and extremely potent antitumor activity","volume":"43","author":"Shi","year":"2004","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.yexmp.2026.105033_bb0550","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/bjh.16060","article-title":"Essential role of PTPN11 mutation in enhanced haematopoietic differentiation potential of induced pluripotent stem cells of juvenile myelomonocytic leukaemia","volume":"187","author":"Shigemura","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0555","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ccell.2015.05.008","article-title":"Erk negative feedback control enables pre-B cell transformation and represents a therapeutic target in acute lymphoblastic Leukemia","volume":"28","author":"Shojaee","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexmp.2026.105033_bb0560","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13035","article-title":"Haematopoietic stem cells require a highly regulated protein synthesis rate","volume":"509","author":"Signer","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2026.105033_bb0565","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-025-10692-z","article-title":"Curcumin and acute myeloid leukemia: a golden hope, updated insights","volume":"52","author":"Soleimani Samarkhazan","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.yexmp.2026.105033_bb0570","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73040","article-title":"Inflammatory response in hematopoietic stem and progenitor cells triggered by activating SHP2 mutations evokes blood defects","volume":"11","author":"Solman","year":"2022","journal-title":"ELife"},{"key":"10.1016\/j.yexmp.2026.105033_bb0575","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/leu.2013.270","article-title":"DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia","volume":"28","author":"Stevenson","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2026.105033_bb0580","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa1614359","article-title":"Midostaurin plus chemotherapy for acute myeloid Leukemia with a FLT3 mutation","volume":"377","author":"Stone","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2026.105033_bb0585","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-58651-x","article-title":"STAT5-dependent regulation of CDC25A by miR-16 controls proliferation and differentiation in FLT3-ITD acute myeloid leukemia","volume":"10","author":"Sueur","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2026.105033_bb0590","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007614","article-title":"Deletion of the protein tyrosine phosphatase PTPN22 for adoptive T cell therapy facilitates CTL effector function but promotes T cell exhaustion","volume":"11","author":"Teagle","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.yexmp.2026.105033_bb0595","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202402405R","article-title":"PTPN2 negatively regulates macrophage immune responses and cellular bioenergetics","volume":"39","author":"Vinette","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.yexmp.2026.105033_bb0600","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1038\/onc.2016.523","article-title":"The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia","volume":"36","author":"Wakim","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.yexmp.2026.105033_bb0605","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1182\/blood-2008-01-133785","article-title":"Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts","volume":"111","author":"Walter","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2026.105033_bb0610","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.1021\/acs.jmedchem.0c00471","article-title":"Discovery of SHP2-D26 as a first, potent, and effective PROTAC degrader of SHP2 protein","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yexmp.2026.105033_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110750","article-title":"Inhibitory effects of Paris saponin I, II, VI and VII on HUVEC cells through regulation of VEGFR2, PI3K\/AKT\/mTOR, Src\/eNOS, PLC\u03b3\/ERK\/MERK, and JAK2-STAT3 pathways","volume":"131","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexmp.2026.105033_bb0620","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.122.318205","article-title":"Repair of limb ischemia is dependent on hematopoietic stem cell specific-SHP-1 regulation of TGF-\u03b21","volume":"43","author":"Wang","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0625","doi-asserted-by":"crossref","DOI":"10.1007\/s10565-024-09965-3","article-title":"Targeting protein tyrosine phosphatase non-receptor type 6 (PTPN6) as a therapeutic strategy in acute myeloid leukemia","volume":"41","author":"Wang","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0630","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pharmthera.2018.05.014","article-title":"Targeting phosphatases of regenerating liver (PRLs) in cancer","volume":"190","author":"Wei","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yexmp.2026.105033_bb0635","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-020-0192-5","article-title":"Protein tyrosine phosphatase 4A3 (PTP4A3\/PRL-3) drives migration and progression of T-cell acute lymphoblastic leukemia in vitro and in vivo","volume":"9","author":"Wei","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.yexmp.2026.105033_bb0640","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-21-0694","article-title":"PTP1B is an intracellular checkpoint that limits T-cell and CAR T-cell antitumor immunity","volume":"12","author":"Wiede","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.yexmp.2026.105033_bb0645","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036244","article-title":"PTEN in regulating hematopoiesis and leukemogenesis","volume":"10","author":"Wu","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.yexmp.2026.105033_bb0650","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/14728222.2024.2344695","article-title":"Targeting PRL phosphatases in hematological malignancies","volume":"28","author":"Xiao","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.yexmp.2026.105033_bb0655","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ni822","article-title":"Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms","volume":"3","author":"Xu","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yexmp.2026.105033_bb0660","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2024.2375045","article-title":"Regulation of STAT5 phosphorylation and interaction with SHP1 by lnc-AC004893, a long non-coding RNA overexpressed in myeloproliferative neoplasms","volume":"29","author":"Yang","year":"2024","journal-title":"Hematology"},{"key":"10.1016\/j.yexmp.2026.105033_bb0665","article-title":"\u03b4-Tocotrienol induces human bladder cancer cell growth arrest, apoptosis and chemosensitization through inhibition of STAT3 pathway","volume":"10","author":"Ye","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2026.105033_bb0670","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2011-01-331157","article-title":"SHP2 tyrosine phosphatase stimulates CEBPA gene expression to mediate cytokine-dependent granulopoiesis","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2026.105033_bb0675","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature04747","article-title":"PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention","volume":"441","author":"Zhang","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2026.105033_bb0680","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/10428194.2024.2441855","article-title":"Molecular, clinical, and prognostic implications of RAS pathway alterations in adult acute myeloid leukemia","volume":"66","author":"Zhang","year":"2025","journal-title":"Leuk. Lymphoma"},{"issue":"Pt 1","key":"10.1016\/j.yexmp.2026.105033_bb0685","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1042\/bj3380035","article-title":"Tyrosine phosphatase SHP-2 dephosphorylates the platelet-derived growth factor receptor but enhances its downstream signalling","volume":"338","author":"Zhao","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexmp.2026.105033_bb0690","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38314","article-title":"T-ALL leukemia stem cell 'stemness' is epigenetically controlled by the master regulator SPI1","volume":"7","author":"Zhu","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.yexmp.2026.105033_bb0695","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1021\/acs.jproteome.2c00481","article-title":"An integrated proteomic strategy to identify SHP2 substrates","volume":"21","author":"Zhu","year":"2022","journal-title":"J. Proteome Res."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:36:57Z","timestamp":1783021017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480026000122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":139,"alternative-id":["S0014480026000122"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105033","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory role of protein tyrosine phosphatases in hematopoiesis and leukemogenesis","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105033"}}